eflornithine has been researched along with Cancer of Liver in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maghsoudloo, M; Murphy, GM; Santos, AA; Stubbs, AP; Wilkinson, ML | 1 |
| Mai, M; Nishioka, K; Takahashi, Y | 1 |
| Fujita, T; Koizumi, T; Matsui, T; Nakagawa, T; Nakao, Y; Watanabe, S | 1 |
| Barlow, JL; Glenn, J; Harvey, HA; Lipton, A; Miller, SE; Strauss, M; Taylor, JB; Weidner, WA; White-Hershey, D | 1 |
| Hollingdale, MR; McCann, PP; Sjoerdsma, A | 1 |
5 other study(ies) available for eflornithine and Cancer of Liver
| Article | Year |
|---|---|
Polyamine metabolism in human hepatocellular cancer cells (Hep-G2).
Topics: Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line; DNA, Neoplasm; Eflornithine; Humans; Liver Neoplasms; Polyamines; Putrescine; Spermidine; Spermine; Tumor Cells, Cultured | 1994 |
alpha-difluoromethylornithine induces apoptosis as well as anti-angiogenesis in the inhibition of tumor growth and metastasis in a human gastric cancer model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Division; Disease Models, Animal; Eflornithine; Endothelium, Vascular; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Proliferating Cell Nuclear Antigen; Stomach Neoplasms; Tumor Cells, Cultured | 2000 |
Effects of alpha-difluoromethyl ornithine on alpha-fetoprotein and albumin secretion in human hepatoma cell line, PLC/PRF/5.
Topics: Albumins; alpha-Fetoproteins; Carcinoma, Hepatocellular; Cell Line; Cycloheximide; Dose-Response Relationship, Drug; Eflornithine; Humans; Liver Neoplasms; Ornithine | 1985 |
A phase I study of hepatic arterial infusion using difluoromethylornithine.
Topics: Adult; Aged; Drug Evaluation; Eflornithine; Hearing Loss, Bilateral; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged | 1989 |
Plasmodium berghei: inhibitors of ornithine decarboxylase block exoerythrocytic schizogony.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Eflornithine; Erythrocytes; Humans; Liver Neoplasms; Malaria; Mice; Mice, Inbred A; Mice, Inbred Strains; Ornithine; Ornithine Decarboxylase Inhibitors; Plasmodium berghei; Primaquine; Spermidine | 1985 |